36Kr learned that Revelyx Bio Inc. (hereinafter referred to as "Revelyx") has recently completed a Series A financing of tens of millions of dollars. This round of financing was exclusively led by NRL Capital, and the raised funds will be used to advance the clinical research and commercial expansion of the company's products globally
